Genprex, Inc.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $1,001 - $15,000 |
Feb 20, 2026 | Feb 5, 2026 | Filing ↗ |
Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $1,001 - $15,000 |
Jan 7, 2026 | Dec 18, 2025 | Filing ↗ |
Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $1,001 - $15,000 |
Dec 2, 2025 | Nov 7, 2025 | Filing ↗ |
Tim MooreHouse · R · NC |
GNPXGenprex, Inc. · Stock |
Purchase $15,001 - $50,000 |
Nov 12, 2025 | Oct 29, 2025 | Filing ↗ |
Whale Activity
- Increased0
- New1
- Held0
- Decreased2
- Closed8
- No prior filing15
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD FIDUCIARY TRUST CO | 3,552 | $10K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,653 | $5K | — |
| UBS Group AG | 443 | $1K | — |
| Tower Research Capital LLC | 260 | $759 | — |
| JONES FINANCIAL COMPANIES LLLP | 56 | $184 | — |
| Robinhood Markets, Inc. | 61 | $179 | — |
| Cheviot Value Management, LLC | 46 | $134 | decreased |
| BlackRock, Inc. | 10 | $29 | — |
| SBI Securities Co., Ltd. | 8 | $23 | new |
| OSAIC HOLDINGS, INC. | 8 | $19 | — |
| Allworth Financial LP | 3 | $9 | — |
| MORGAN STANLEY | 2 | $6 | — |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| LONGNECKER BRENT MDirector | Sale | −10 | $1.23 | $12 | Apr 14, 2026 | Form 4 ↗ |
| LONGNECKER BRENT MDirector | Sale | −8 | $1.23 | $10 | Apr 14, 2026 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −7,168 | $2.00 | $14K | Feb 27, 2026 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Tax withholding | −9,330 | $2.00 | $19K | Feb 27, 2026 | Form 4 ↗ |
| Moreno Toscano Jose AntonioDirector | Grant / award | +9,000 | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Grant / award | +28.5K | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Grant / award | +45.0K | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| LONGNECKER BRENT MDirector | Grant / award | +9,000 | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Wilson William R Jr.Director | Grant / award | +9,000 | $0.00 | $0 | Dec 22, 2025 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −4,500 | $0.23 | $1K | Jun 30, 2025 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Tax withholding | −5,775 | $0.23 | $1K | Jun 30, 2025 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −585 | $0.41 | $240 | Feb 18, 2025 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Tax withholding | −395 | $0.41 | $162 | Feb 18, 2025 | Form 4 ↗ |
| Moreno Toscano Jose AntonioDirector | Grant / award | +4,750 | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Wilson William R Jr.Director | Grant / award | +4,750 | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| LONGNECKER BRENT MDirector | Grant / award | +4,750 | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Confer Ryan M.President, CEO and CFO · Director | Grant / award | +29.4K | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Grant / award | +18.3K | $0.00 | $0 | Dec 5, 2024 | Form 4 ↗ |
| Berger Mark StanleyChief Medical Officer | Tax withholding | −1,319 | $4.40 | $6K | Feb 18, 2024 | Form 4 ↗ |
| Varner John RodneyChairman, President and CEO · Director | Tax withholding | −2,642 | $4.40 | $12K | Feb 18, 2024 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 9,122 | $34K | 0.00% | Aug 31, 2026 |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 70 | $260 | 0.00% | Aug 31, 2026 |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 32 | $119 | 0.00% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list GNPX's shares (CUSIP 372446401), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Corporate Lobbying
No lobbying filings found naming Genprex, Inc. as the client.
Government Contracts
No federal contract awards found for Genprex, Inc..
U.S. Patents
No USPTO patent applications found for Genprex, Inc..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | n/a | $0 | $0 | $0 | $0 |
| Operating income | -$15.5M | -$21.2M | -$31.1M | -$23.8M | -$20.7M |
| Net income | -$16.2M | -$21.1M | -$30.9M | -$23.7M | -$20.7M |
| Operating cash flow | -$15.3M | -$17.9M | -$24.7M | -$17.6M | -$14.3M |
| Cash and equivalents | $7.8M | $1.6M | $6.7M | $21.0M | n/a |
| Total assets | $10.2M | $4.1M | $10.7M | $25.1M | $42.9M |
| Total liabilities | $2.2M | $2.5M | n/a | n/a | $1.6M |
| Shareholders' equity | $8.0M | $1.6M | $7.4M | $22.3M | $41.3M |
As Genprex, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 30, 2026 ↗
Stock Splits
- 1-for-22Reverse splitJul 16, 2026
- 1-for-50Reverse splitOct 21, 2025
- 1-for-40Reverse splitFeb 2, 2024
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
- 8-K · Items 8.01, 9.01Other eventsNov 5, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsNov 4, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsOct 28, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsOct 21, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsAug 18, 2026
EDGAR ↗ - 8-K · Items 3.01, 9.01Delisting noticeAug 5, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsAug 3, 2026
EDGAR ↗ - 8-K · Items 3.01, 8.01, 9.01Delisting notice · Other eventsJul 30, 2026
EDGAR ↗ - 8-K · Items 3.03, 5.03, 7.01, 8.01, 9.01Modification of rights · Bylaw amendment · Reg FD disclosureJul 14, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 22, 2026
EDGAR ↗

